Position in GILD
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$1,442,802
-$142,949 QoQ
Shares Held
11,420
+0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#938
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOWLAND CAPITAL MANAGEMENT LLC holds $45,192,590 across 9 Drug Manufacturers - General names. GILD ranks #5 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
87,734 | $22,281,803 | |
| 2 | ABBV |
AbbVie Inc.
|
29,636 | $7,457,603 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,824 | $5,888,384 | |
| 4 | LLY |
ELI LILLY & Co
|
3,121 | $3,743,421 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
11,420 | $1,442,802 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
22,408 | $1,291,148 | |
| 7 | AMGN |
Amgen Inc
|
3,560 | $1,289,147 | |
| 8 | PFE |
Pfizer Inc
|
51,607 | $1,242,696 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,442,802 | 11,420 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $1,585,751 | 11,378 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $1,358,240 | 11,066 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,228,215 | 11,065 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,226,776 | 11,065 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,239,833 | 11,065 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,208,753 | 13,086 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,277,637 | 15,239 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,125,890 | 16,410 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,361,351 | 18,585 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,714,738 | 21,167 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $1,597,870 | 21,322 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $2,028,944 | 26,326 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $2,221,604 | 26,776 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $2,312,884 | 26,941 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $1,724,173 | 27,949 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $2,170,025 | 35,108 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $2,028,552 | 34,122 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $2,463,149 | 33,923 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $2,412,339 | 34,536 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $2,493,076 | 36,205 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $2,484,829 | 38,447 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $4,159,064 | 71,388 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $6,092,590 | 96,417 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $8,452,320 | 109,856 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $8,855,695 | 118,455 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||